Agimexpharm Pharmaceutical JSC (HSTC:AGP) Marketable Securities: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:AGP Agimexpharm Pharmaceutical JSC HSTC:AGP
14 GF Score
Price ₫32,200.00
! 1 Warning Sign
View Full Analysis

What is Agimexpharm Pharmaceutical JSC Marketable Securities?

Agimexpharm Pharmaceutical JSC HSTC:AGP +0.63% 14 Marketable Securities is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:AGP with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Agimexpharm Pharmaceutical JSC's Marketable Securities for the quarter that ended in . 20 was ₫0.00 Mil.


Agimexpharm Pharmaceutical JSC  (HSTC:AGP) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Agimexpharm Pharmaceutical JSC Marketable Securities Related Terms


Agimexpharm Pharmaceutical JSC Marketable Securities Historical Data

* Premium members only.

The historical data trend for Agimexpharm Pharmaceutical JSC's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agimexpharm Pharmaceutical JSC Marketable Securities Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
Marketable Securities

Agimexpharm Pharmaceutical JSC Semi-Annual Data
Marketable Securities
HSTC:AGP
14GF Score
Agimexpharm Pharmaceutical JSC HSTC:AGP
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agimexpharm Pharmaceutical JSC Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₫0.00 Mil mean?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a Marketable Securities of ₫0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Agimexpharm Pharmaceutical JSC and its competitors.
Is Agimexpharm Pharmaceutical JSC's Marketable Securities too high?
Agimexpharm Pharmaceutical JSC's current Marketable Securities is ₫0.00 Mil. Overall, Agimexpharm Pharmaceutical JSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Agimexpharm Pharmaceutical JSC's Marketable Securities compare to ?
Agimexpharm Pharmaceutical JSC's Marketable Securities of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Agimexpharm Pharmaceutical JSC and its competitors. Agimexpharm Pharmaceutical JSC's current Marketable Securities is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agimexpharm Pharmaceutical JSC stock overvalued right now?
Agimexpharm Pharmaceutical JSC (HSTC:AGP) has a current Marketable Securities of ₫0.00 Mil. The current Marketable Securities is ₫0.00 Mil. Agimexpharm Pharmaceutical JSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Agimexpharm Pharmaceutical JSC (HSTC:AGP), the current Marketable Securities is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Agimexpharm Pharmaceutical JSC Business Description

Comparable Companies
Address 27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
14GF Score

Get the complete analysis for HSTC:AGP

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫32,200.00
Price